FDA Releases Guidance on Major, Minor, and Telephone Amendments to Abbreviated New Drug Applications

Summary

The Food and Drug Administration (FDA) has made available a revised guidance document aimed at simplifying the review process for abbreviated new drug applications (ANDAs), particularly for major, minor, and telephone amendments.